PER® Global Unveils Agendas for First Two 2016 European Congresses
Registration Opens for "Paris Lymphoma" and Immunotherapies in Cancer Congresses
PLAINSBORO, New Jersey, Aug. 1, 2016 /PRNewswire/ -- Physicians' Education Resource®, LLC (PER®), the leading source for oncology and hematology continuing medical education (CME), and its international affiliate, PER Global, LLC, today unveiled full agendas for both its first European Congress on Hematology™: Focus on Lymphoid Malignancies, and its first European Congress on Immunotherapies in Cancer™.
Being held from September 23-24, at the W Barcelona, in Barcelona, Spain, the 1st Annual European Congress on Immunotherapies in Cancer™ is a two-day comprehensive and interactive program focused exclusively on immunotherapies and their practical application to the management of cancer. Highlights of the comprehensive agenda include sessions on Immunotherapy for Gastrointestinal Cancers with Josep Tabernero, MD, PhD; Chimeric Antigen Receptor T-Cell Therapy with Carl H. June, MD; and Resistance to Immunotherapy: Mechanisms and Clinical Approaches with Antoni Ribas, MD, PhD. Registration information and the agenda are both accessible online.
The European Accreditation Council for Continuing Medical Education (EACCME) has approved this congress for CME accreditation.
The European Congress on Hematology™: Focus on Lymphoid Malignancies, also known as "Paris Lymphoma™," is being held November 3-5, at the Hyatt Regency Paris Étoile, in Paris, France. This highly practical and interactive program will focus on improving patient care for the clinician who manages patients with lymphoid malignancies. Highlights of this inclusive agenda include New Treatment Options in Relapsed/Refractory Chronic Lymphocytic Leukemia with Jennifer R. Brown, MD, PhD; Managing Elderly Patients with Multiple Myeloma with Shaji Kumar, MD; and Choosing First-Line Therapy for Patients with Follicular Lymphoma with Gilles A. Salles, MD, PhD. Registration information and the agenda are both accessible online.
An application has been submitted to the EACCME for CME accreditation of this congress.
"We are very excited to share the comprehensive agendas of PER® Global's first two congresses so that physicians can see the data that will be discussed at PER's newest European congresses," said PER president, Phil Talamo. "Given the fast pace at which practice-changing evidence continues to emerge, oncologists continue to face the constant challenge to maintain state-of-the-art care in managing patients, and we are confident that our new European meetings will provide them with the most relevant guidance from the most reputable oncology experts in the world."
PER Global is the educational resource of choice for live and online activities focusing on oncology and hematology. Serving the oncology health care community, including physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other health care providers who are involved in the treatment and management of patients with cancer, PER Global plans, develops, implements and evaluates educational activities using a wide variety of formats, as well as leading national and international faculty, targeted to the needs of health care providers.
About PER
As a leader in CME for nearly 20 years, PER educates more oncologists and hematologists through live annual CME-certified conferences than any other medical education provider in the United States. PER provides high-quality, evidence-based, CME-certified activities that translate the science of oncology into the art of patient care by featuring leading national and international faculty that focus on practice-changing advances that help the busy oncologist stay up-to-date with cutting-edge oncology knowledge and treatments. Accredited by the Accreditation Council for Continuing Medical Education, PER serves the broader oncology health care community, including physicians, nurses, nurse practitioners, physician assistants and pharmacists. PER also consists of PER Global, which carries PER's mission of advancing cancer care through professional education outside the United States. PER is part of Michael J. Hennessy Associates Inc., a full-service health care communications company offering education, research and medical media.
Share this article